Equity Overview
Price & Market Data
Price: $5.25
Daily Change: $0.00 / 0.00%
Daily Range: $0 - $0
Market Cap: $13,337,720
Daily Volume: 0
Performance Metrics
1 Week: -7.57%
1 Month: -33.96%
3 Months: -46.97%
6 Months: -25.00%
1 Year: -88.89%
YTD: -48.81%
Company Details
Employees: 16
Sector: Health technology
Industry: Biotechnology
Country: United States
Details
Intensity Therapeutics, Inc., a late-stage clinical biotechnology company, engages in the provision of treatment for the regional and systemic nature of cancer in the United States. Its lead product candidate includes INT230-6, which is in Phase 3 clinical studies for the treatment of soft tissue sarcoma; and neoadjuvant and metastatic triple negative breast cancer which is in Phase 2 clinical trials. The company was incorporated in 2012 and is headquartered in Shelton, Connecticut.